Successful conversion therapy for advanced hepatocellular carcinoma with biliary tumor thrombus and bilateral lobe involvement: A case report
World Journal of Gastroenterology · 28.06.2026 · 32 (24)
DOI: 10.3748/wjg.119220 ↗Kurz gefasst
Fallbericht in der Zeitschrift World Journal of Gastroenterology, online erschienen am 28.06.2026. Verfasst von Yu Zhang und 6 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Bilateral multilobular hepatocellular carcinoma (HCC) complicated by HCC-derived biliary tumor thrombus is classified as an advanced-stage disease. Owing to the heavy tumor burden, obstructive jaundice, and other issues, the prognosis with conventional treatment is extremely poor, and most patients lose the opportunity for radical resection. The advent of immune-combined targeted conversion therapy has brought new hope for such patients. CASE SUMMARY A 36-year-old man with ≥ 10-year history of hepatitis B was admitted for upper abdominal distension and pain. Imaging demonstrated bilateral multifocal HCC with a left HCC-derived biliary tumor thrombus (Chinese Liver Cancer stage IIIa, Barcelona Clinic Liver Cancer stage C), obstructive jaundice, and cirrhosis. The tumor was initially considered unresectable. The patient received conversion therapy with camrelizumab, apatinib mesylate, and radiofrequency ablation. After five cycles, both the tumors and thrombus regressed, and tumor marker levels decreased markedly. The response was assessed as partial response according to mRECIST 1.1 criteria. Liver function improved from Child-Pugh class B to class A, allowing radical surgical resection with negative margins. Postoperative maintenance therapy was administered for 1 year. No recurrence was detected during follow-up. CONCLUSION For advanced bilateral multi-lobular HCC complicated by HCC-derived biliary tumor thrombus, immune-targeted therapy combined with local ablation reduces tumor burden, eliminates thrombus, converts unresectable disease to resectable status, and achieves effective short-term disease control.
Zitieren
APA
Zhang, Y., Zhang, L., Meng, B., Wang, Y., Yang, N., Li, Q., & Zhang, M. (2026). Successful conversion therapy for advanced hepatocellular carcinoma with biliary tumor thrombus and bilateral lobe involvement: A case report. World Journal of Gastroenterology, 32(24). https://doi.org/10.3748/wjg.119220
Vancouver
Zhang Y, Zhang L, Meng B, Wang Y, Yang N, Li Q, et al. Successful conversion therapy for advanced hepatocellular carcinoma with biliary tumor thrombus and bilateral lobe involvement: A case report. World Journal of Gastroenterology. 2026;32(24). doi:10.3748/wjg.119220
BibTeX
@article{Zhang2026,
author = {Zhang, Yu and Zhang, Lu-Yang and Meng, Bo and Wang, Yun-Jian and Yang, Nan-Mu and Li, Qiong and Zhang, Min},
title = {Successful conversion therapy for advanced hepatocellular carcinoma with biliary tumor thrombus and bilateral lobe involvement: A case report},
journal = {World Journal of Gastroenterology},
year = {2026},
volume = {32},
number = {24},
doi = {10.3748/wjg.119220}
}
EUVIMED